Table of Contents
1 Recombinant Peptides Market Overview
1.1 Recombinant Peptides Product Overview
1.2 Recombinant Peptides Market Segment by Type
1.2.1 Glucagon
1.2.2 Calcitonin
1.2.3 Other
1.3 Global Recombinant Peptides Market Size by Type
1.3.1 Global Recombinant Peptides Sales and Growth by Type
1.3.2 Global Recombinant Peptides Sales and Market Share by Type ( 2016 - 2021)
1.3.3 Global Recombinant Peptides Revenue and Market Share by Type ( 2016 - 2021)
1.3.4 Global Recombinant Peptides Price by Type ( 2016 - 2021)
2 Global Recombinant Peptides Market Competition by Company
2.1 Global Recombinant Peptides Sales and Market Share by Company ( 2016 - 2021)
2.2 Global Recombinant Peptides Revenue and Share by Company ( 2016 - 2021)
2.3 Global Recombinant Peptides Price by Company ( 2016 - 2021)
2.4 Global Top Players Recombinant Peptides Manufacturing Base Distribution, Sales Area, Product Types
2.5 Recombinant Peptides Market Competitive Situation and Trends
2.5.1 Recombinant Peptides Market Concentration Rate
2.5.2 Global Recombinant Peptides Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Recombinant Peptides Company Profiles and Sales Data
3.1 Sandoz Pharma
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Recombinant Peptides Product Category, Application and Specification
3.1.3 Sandoz Pharma Recombinant Peptides Sales, Revenue, Price and Gross Margin( 2016 - 2021)
3.1.4 Main Business Overview
3.2 Stada Arzneimittel
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Recombinant Peptides Product Category, Application and Specification
3.2.3 Stada Arzneimittel Recombinant Peptides Sales, Revenue, Price and Gross Margin( 2016 - 2021)
3.2.4 Main Business Overview
3.3 Amgen
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Recombinant Peptides Product Category, Application and Specification
3.3.3 Amgen Recombinant Peptides Sales, Revenue, Price and Gross Margin( 2016 - 2021)
3.3.4 Main Business Overview
3.4 Hospira
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Recombinant Peptides Product Category, Application and Specification
3.4.3 Hospira Recombinant Peptides Sales, Revenue, Price and Gross Margin( 2016 - 2021)
3.4.4 Main Business Overview
3.5 Actavis
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Recombinant Peptides Product Category, Application and Specification
3.5.3 Actavis Recombinant Peptides Sales, Revenue, Price and Gross Margin( 2016 - 2021)
3.5.4 Main Business Overview
3.6 Cipla Ltd.
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Recombinant Peptides Product Category, Application and Specification
3.6.3 Cipla Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin( 2016 - 2021)
3.6.4 Main Business Overview
3.7 Wockhardt Ltd.
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Recombinant Peptides Product Category, Application and Specification
3.7.3 Wockhardt Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin( 2016 - 2021)
3.7.4 Main Business Overview
3.8 Biocon Ltd.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Recombinant Peptides Product Category, Application and Specification
3.8.3 Biocon Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin( 2016 - 2021)
3.8.4 Main Business Overview
4 Recombinant Peptides Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Recombinant Peptides Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia - Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Recombinant Peptides Sales and Revenue by Regions
4.2.1 Global Recombinant Peptides Sales and Market Share by Regions ( 2016 - 2021)
4.2.2 Global Recombinant Peptides Revenue and Market Share by Regions ( 2016 - 2021)
4.2.3 Global Recombinant Peptides Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
4.3 North America Recombinant Peptides Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Recombinant Peptides Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia - Pacific Recombinant Peptides Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Recombinant Peptides Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Recombinant Peptides Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Recombinant Peptides Application/End Users
5.1 Recombinant Peptides Segment by Application
5.1.1 Oncology
5.1.2 Blood Disorders
5.1.3 Infectious Diseases
5.1.4 Autoimmune Diseases
5.1.5 Other
5.2 Global Recombinant Peptides Product Segment by Application
5.2.1 Global Recombinant Peptides Sales by Application
5.2.2 Global Recombinant Peptides Sales and Market Share by Application ( 2016 - 2021)
6 Global Recombinant Peptides Market Forecast
6.1 Global Recombinant Peptides Sales, Revenue Forecast ( 2021 - 2027)
6.1.1 Global Recombinant Peptides Sales and Growth Rate Forecast ( 2021 - 2027)
6.1.1 Global Recombinant Peptides Revenue and Growth Rate Forecast ( 2021 - 2027)
6.2 Global Recombinant Peptides Forecast by Regions
6.2.1 North America Recombinant Peptides Sales and Revenue Forecast ( 2021 - 2027)
6.2.2 Europe Recombinant Peptides Sales and Revenue Forecast ( 2021 - 2027)
6.2.3 Asia - Pacific Recombinant Peptides Sales and Revenue Forecast ( 2021 - 2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Recombinant Peptides Sales and Revenue Forecast ( 2021 - 2027)
6.2.5 Middle East and Africa Recombinant Peptides Sales and Revenue Forecast ( 2021 - 2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Recombinant Peptides Forecast by Type
6.3.1 Global Recombinant Peptides Sales and Revenue Forecast by Type ( 2021 - 2027)
6.3.2 Glucagon Gowth Forecast
6.3.3 Calcitonin Gowth Forecast
6.4 Recombinant Peptides Forecast by Application
6.4.1 Global Recombinant Peptides Sales Forecast by Application ( 2021 - 2027)
6.4.2 Global Recombinant Peptides Forecast in Oncology
6.4.3 Global Recombinant Peptides Forecast in Blood Disorders
7 Recombinant Peptides Upstream Raw Materials
7.1 Recombinant Peptides Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Recombinant Peptides Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure Recombinant Peptides Product Picture
Figure Global Recombinant Peptides Revenue (Million USD) Status and Outlook ( 2016 - 2027)
Figure Global Recombinant Peptides Sales (K MT) Status and Outlook ( 2016 - 2027)
Figure Product Picture of Glucagon
Table Major Players of Glucagon
Figure Global Glucagon Sales (K MT) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Calcitonin
Table Major Players of Calcitonin
Figure Global Calcitonin Sales (K MT) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Other
Table Major Players of Other
Figure Global Other Sales (K MT) and Growth Rate (%)( 2016 - 2021)
Table Global Recombinant Peptides Sales (K MT) and Growth Rate (%) Comparison by Type
Table Global Recombinant Peptides Sales (K MT) by Type ( 2016 - 2021)
Table Global Recombinant Peptides Sales Share (%) by Type ( 2016 - 2021)
Figure Global Recombinant Peptides Sales Market Share (%) by Type ( 2016 - 2021)
Figure Global Recombinant Peptides Sales Market Share (%) by Type in 2020
Table Global Recombinant Peptides Revenue (Million USD) by Type ( 2016 - 2021)
Table Global Recombinant Peptides Revenue Share (%) by Type ( 2016 - 2021)
Figure Global Recombinant Peptides Revenue Share (%) by Type ( 2016 - 2021)
Figure 2020 Global Recombinant Peptides Revenue Market Share (%) by Type
Table Global Recombinant Peptides Price (USD/MT) by Type ( 2016 - 2021)
Table Global Recombinant Peptides Sales (K MT) by Company ( 2016 - 2021)
Table Global Recombinant Peptides Sales Share (%) by Company ( 2016 - 2021)
Figure Global Recombinant Peptides Sales Share (%) by Company in 2020
Table Global Recombinant Peptides Revenue (Million USD) by Company ( 2016 - 2021)
Table Global Recombinant Peptides Revenue Share (%) by Company ( 2016 - 2021)
Figure Global Recombinant Peptides Revenue Share (%) by Company in 2020
Table Global Market Recombinant Peptides Average Price (USD/MT) by Company ( 2016 - 2021)
Table Global Recombinant Peptides Top Players Manufacturing Base Distribution and Sales Area
Table Global Recombinant Peptides Top Players Product Category
Figure Global Recombinant Peptides Market Share (%) of Top 5 Players
Figure Global Recombinant Peptides Market Share (%) of Top 10 Players
Table Sandoz Pharma Basic Information List
Table Sandoz Pharma Recombinant Peptides Product Category, Application and Specification
Table Sandoz Pharma Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Sandoz Pharma Recombinant Peptides Sales Growth Rate ( 2016 - 2021)
Figure Sandoz Pharma Recombinant Peptides Sales Global Market Share (%)( 2016 - 2021)
Table Stada Arzneimittel Basic Information List
Figure Stada Arzneimittel Recombinant Peptides Product Category, Application and Specification
Table Stada Arzneimittel Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Stada Arzneimittel Recombinant Peptides Sales Growth Rate ( 2016 - 2021)
Figure Stada Arzneimittel Recombinant Peptides Sales Global Market Share (%)( 2016 - 2021)
Table Amgen Basic Information List
Figure Amgen Recombinant Peptides Product Category, Application and Specification
Table Amgen Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Amgen Recombinant Peptides Sales Growth Rate ( 2016 - 2021)
Figure Amgen Recombinant Peptides Sales Global Market Share (%)( 2016 - 2021)
Table Hospira Basic Information List
Figure Hospira Recombinant Peptides Product Category, Application and Specification
Table Hospira Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Hospira Recombinant Peptides Sales Growth Rate ( 2016 - 2021)
Figure Hospira Recombinant Peptides Sales Global Market Share (%)( 2016 - 2021)
Table Actavis Basic Information List
Figure Actavis Recombinant Peptides Product Category, Application and Specification
Table Actavis Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Actavis Recombinant Peptides Sales Growth Rate ( 2016 - 2021)
Figure Actavis Recombinant Peptides Sales Global Market Share (%)( 2016 - 2021)
Table Cipla Ltd. Basic Information List
Figure Cipla Ltd. Recombinant Peptides Product Category, Application and Specification
Table Cipla Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Cipla Ltd. Recombinant Peptides Sales Growth Rate ( 2016 - 2021)
Figure Cipla Ltd. Recombinant Peptides Sales Global Market Share (%)( 2016 - 2021)
Table Wockhardt Ltd. Basic Information List
Figure Wockhardt Ltd. Recombinant Peptides Product Category, Application and Specification
Table Wockhardt Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Wockhardt Ltd. Recombinant Peptides Sales Growth Rate ( 2016 - 2021)
Figure Wockhardt Ltd. Recombinant Peptides Sales Global Market Share (%)( 2016 - 2021)
Table Biocon Ltd. Basic Information List
Figure Biocon Ltd. Recombinant Peptides Product Category, Application and Specification
Table Biocon Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Biocon Ltd. Recombinant Peptides Sales Growth Rate ( 2016 - 2021)
Figure Biocon Ltd. Recombinant Peptides Sales Global Market Share (%)( 2016 - 2021)
Table Global Recombinant Peptides Market Size Comparison by Regions ( 2016 - 2027)
Figure North America Recombinant Peptides Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure Asia - Pacific Recombinant Peptides Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure Europe Recombinant Peptides Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure South America Recombinant Peptides Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure Middle East and Africa Recombinant Peptides Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Table Global Recombinant Peptides Sales (K MT) by Regions ( 2016 - 2021)
Table Global Recombinant Peptides Sales Market Share (%) by Regions ( 2016 - 2021)
Figure Global Recombinant Peptides Sales Market Share (%) by Regions ( 2016 - 2021)
Figure 2020 Global Recombinant Peptides Sales Market Share (%) by Regions
Table Global Recombinant Peptides Revenue (Million USD) by Regions ( 2016 - 2021)
Table Global Recombinant Peptides Revenue Market Share (%) by Regions ( 2016 - 2021)
Figure Global Recombinant Peptides Revenue Market Share (%) by Regions ( 2016 - 2021)
Figure 2020 Global Recombinant Peptides Revenue Market Share (%) by Regions
Table Global Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure North America Recombinant Peptides Sales Growth Rate
Table North America Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure United States Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure United States Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Canada Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Canada Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Mexico Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Mexico Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Europe Recombinant Peptides Sales Growth Rate
Table Europe Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Germany Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Germany Recombinant Peptides Revenue (Million USD) ( 2016 - 2021)
Figure UK Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure UK Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure France Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure France Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Italy Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Italy Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Russia Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Russia Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Turkey Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Turkey Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Asia - Pacific Recombinant Peptides Sales Growth Rate
Table Asia - Pacific Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure China Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure China Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Japan Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Japan Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Korea Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Korea Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Southeast Asia Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Southeast Asia Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Indonesia Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Indonesia Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Thailand Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Thailand Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Malaysia Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Malaysia Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Philippines Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Philippines Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Vietnam Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Vietnam Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure India Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure India Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Australia Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Australia Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure South America Recombinant Peptides Sales Growth Rate
Table South America Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure Brazil Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure Brazil Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Middle East and Africa Recombinant Peptides Sales Growth Rate
Table Middle East and Africa Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)( 2016 - 2021)
Figure North Africa Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure North Africa Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure GCC Countries Recombinant Peptides Sales (K MT)( 2016 - 2021)
Figure GCC Countries Recombinant Peptides Revenue (Million USD)( 2016 - 2021)
Figure Oncology Examples
Figure Blood Disorders Examples
Figure Infectious Diseases Examples
Figure Autoimmune Diseases Examples
Figure Other Examples
Table Global Recombinant Peptides Sales (K MT) Comparison by Application ( 2016 - 2027)
Table Global Recombinant Peptides Sales (K MT) by Application ( 2016 - 2021)
Table Global Recombinant Peptides Sales Share (%) by Application ( 2016 - 2021)
Figure Global Recombinant Peptides Sales Market Share (%) by Application ( 2016 - 2021)
Figure Global Rec
